Patent ID: 9708604
Date: 2017-07-18
CPC Classifications: A61P,C12N

Claim:
1. A method of upregulating a function of and/or the expression of a Delta-like 1 homolog (DLK1) polynucleotide having SEQ ID NOS: 1 or 2 in human patient cells or tissues in vivo or in vitro comprising: contacting said cells or tissues with at least one antisense oligonucleotide of 12 to 30 nucleotides in length that specifically targets a region of a natural antisense oligonucleotide of the Delta-like 1 homolog (DLK1) polynucleotide selected from SEQ ID NO: 3; thereby upregulating a function of and/or the expression of the Delta-like 1 homolog (DLK1) polynucleotide in patient cells or tissues in vivo or in vitro.